NASDAQ
Gracell Biotechnologies Inc. (GRCL) has a current ratio of 6.78x as of Monday, May 25, 2026. This represents a 52.28% decrease compared to its 12-month average of 14.21x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.